Metuchen, NJ — A highly competitive ITN research grant from European Commission’s research program Horizon 2020 has been awarded to NattoPharma’s International Research Network coordinated by Queen Mary University of London. The partnership is comprised of four other highly ranked research university departments in Europe [University College Dublin (part of...
Oslo, Norway and Metuchen, NJ — The kidney research and clinical journal Nephron, and the American Journal of Hypertension have individually published new papers linking vascular calcification and vascular and arterial stiffness to the vitamin K-dependent protein known as MGP (matrix GLA-protein). The Nephron paper titled “Correlations of Plasma Desphosphorylated...
Nagoya, Japan—A team of Japanese researchers has offered a new theory for the cause of several metabolic diseases: impaired vitamin K2-dependent processes. The group notes that cardiovascular disease (CVD) and type-2 diabetes mellitus (DM) seem to be linked, but a causal relationship is unknown. Many times, patients with these diseases...
Oslo, Norway—Vitamin K2 is a rising star in the bone and heart health categories, and new research offers even more insight into why the vitamin supports circulatory health. Researchers specifically looked at the effect of vitamin K2 (as menaquinone-7 [MK-7 as MenaQ7 from Nattopharma, based here]) on inflammatory markers like...
Bone health is probably one area your customers feel pretty comfortable with. The words calcium and vitamin D appear on labels of everyday food items and brands have been advertising their bone health benefits for years. However, nutrition is a science that is always changing and consumers need to understand...
